SHIKARI® Q-VEDO
Enzyme immunoassay for the quantitative determination of Vedolizumab(Entyvio®) in human serum and plasma
Enzyme immunoassay for the quantitative determination of Vedolizumab (Entyvio®) in serum and plasma. The Matriks Biotek Shikari Q-VEDO ELISA has been especially developed for the quantitative analysis of Vedolizumab in serum and plasma samples.
Click the diagram to see bigger
| Required Volume (µl) | 10 |
|---|---|
| Total Time (min) | 140 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | 30 |
| Spike Recovery (%) | Between 85-115 |
| Shelf Life (year) | 1 |